InspireMD Inc reports results for the quarter ended December 31 - Earnings Summary
12/03/2025 13:30
InspireMD Inc NSPR.OQ reported a quarterly adjusted loss of 18 cents per share for the quarter ended December 31, lower than the same quarter last year, when the company reported EPS of -16 cents. The mean expectation of two analysts for the quarter was for a loss of 19 cents per share. Wall Street expected results to range from -20 cents to -19 cents per share. Revenue rose 10.7% to $1.95 million from a year ago; analysts expected $1.82 million. InspireMD Inc's reported EPS for the quarter was a loss of 18 cents. The company reported a quarterly loss of $9.17 million. InspireMD Inc shares had risen by 6.1% this quarter. FORECAST CHANGES The mean earnings estimate of analysts was unchanged in the last three months. In the last 30 days, there have been no earnings estimate revisions by analysts covering the company. RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" Wall Street's median 12-month price target for InspireMD Inc is $4.75 This summary was machine generated from LSEG data March 12 at 01:30 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Dec. 31 2024 | -0.19 | -0.18 | Beat |
| Sep. 30 2024 | -0.20 | -0.16 | Beat |
| Jun. 30 2024 | -0.19 | -0.22 | Missed |
| Mar. 31 2024 | -0.15 | -0.21 | Missed |